Back to top

Cellectar Biosciences initiated with a Buy at Brookline

Brookline initiated coverage of Cellectar Biosciences (CLRB) with a Buy rating and $15 price target Published first on TheFly – the ultimate source...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cellectar Biosciences, Inc. (CLRB)